CE18 - Innovation biomédicale

Engineering a bacterial secretion platform for rapid, high-yield, low-cost production of peptides and proteins for diagnosis and biomedicine – BactCellFactory

Submission summary

Recombinant protein production is a multi-billion euro market with critical applications for industy and medicine. Various methods of production are available using cellular organisms of all domains of life. Yet, most rely on expensive, and time-consuming steps performed in dedicated facilities to obtain the final pure protein. This project aims at developing reliable and simple methods of protein production by engineering bacterial secretion machineries. We will use both fundamental and applied viewpoints to reprogram bacterial secretion for high-yield low-cost in vitro production of proteins. We will further engineer those systems for production of therapeutical proteins. We expect this project to lower the barrier for heterologous production of tailored proteins with useful applications in various fields such as rapid prototyping for research, personalized medicine, low-cost/low-material production of medical proteins in crisis situation, and development of innovative in vivo therapies.

Project coordination

Thibaud RENAULT (Acides nucléiques : Régulations Naturelles et Artificielles)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.


INSERM U1212 ARNA Acides nucléiques : Régulations Naturelles et Artificielles

Help of the ANR 261,050 euros
Beginning and duration of the scientific project: August 2024 - 36 Months

Useful links

Explorez notre base de projets financés



ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter